3 completed, 1 unknown. 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow HU 211: new trials by email Literature Review of HU 211 trials Research Report on HU 211
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours Dexanabinol, Sorafenib, Nab-paclitaxel - Hepatocellular Carcinoma, Pancreatic Cancer | Phase 1 | Unknown | e-Therapeutics PLC | 112 | 2015-04-01 | 2016-04-06 |
| Dexanabinol in Patients With Brain Cancer Dexanabinol - Brain Cancer | Phase 1 | Completed | Santosh Kesari, M.D., Ph.D. | 26 | 2012-06-01 | 2019-11-14 |
| A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours Dexanabinol, Cremophor - Solid Tumour | Phase 1 | Completed | e-Therapeutics PLC | 40 | 2012-01-01 | 2017-02-09 |
| Dexanabinol in Severe Traumatic Brain Injury Dexanabinol - Traumatic Brain Injury | Phase 3 | Completed | Pharmos | 860 | 2001-01-01 | 2006-05-05 |
Neoplasms (2) · Astrocytoma (1) · Brain Injuries, Traumatic (1) · Brain Neoplasms (1) · Carcinoma, Hepatocellular (1) · Glioblastoma (1) · Glioma (1) · Meningioma (1) · Neoplasm Metastasis (1) · Oligodendroglioma (1) · Pancreatic Neoplasms (1)
e-Therapeutics PLC (2) · Pharmos (1) · Santosh Kesari, M.D., Ph.D. (1)
United Kingdom (2) · Germany (1) · Poland (1) · Spain (1) · United States (1)
Alan Anthoney, MD (1) · Andrew Maas, M.D. (1) · Jeff Evans, MD (1) · Ruth Plummer, MD (1) · Santosh Kesari, MD, PhD (1)